Publications by authors named "Hazel B Breitz"

Claim this Profile
P
Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.
John R Eckardt, Dimitri L Bentsion, Oleg N Lipatov, Igor S Polyakov, Frederick R Mackintosh, Hazel B Breitz

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Barry W Wessels, Mark W Konijnenberg, Roger G Dale, Hazel B Breitz, Marta Cremonesi

J Nucl Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
Hazel B Breitz, Richard E Wendt, Michael S Stabin, Sui Shen, William D Erwin

J Nucl Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based red marrow dosimetry: where's the beef?
Jeffry A Siegel, Richard B Sparks, Robert M Sharkey, Barry W Wessels, Wesley E Bolch, Hazel B Breitz

J Nucl Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Barry W Wessels, Wesley E Bolch, Lionel G Bouchet, Hazel B Breitz, Gerald L Denardo

J Nucl Med· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Andres Forero, Paul L Weiden, Julie M Vose, Susan J Knox, Albert F LoBuglio, Hazel B Breitz

Blood· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis